Art's-Way Manufacturing Co., Inc. filings document operating results, segment performance, governance matters, and shareholder voting for the agricultural equipment and modular buildings manufacturer. Form 8-K reports include results of operations and financial condition for quarterly and fiscal periods, with disclosures tied to Agricultural Products, Modular Buildings, continuing operations, and the completed wind-down of the former Tools segment.
Proxy and annual-meeting filings cover board elections, auditor ratification, advisory executive-compensation votes, equity-award disclosures, and amendments to the 2020 Equity Incentive Plan. The company's filing record also documents shareholder-vote frequency decisions and related governance procedures.
Art’s-Way Manufacturing Co., Inc. reported higher revenue but lower profitability for the quarter and first half ended May 31, 2026. For the three months, sales were $7,854,000 versus $6,337,000 a year earlier, while operating income declined to $287,000 from $510,000 and net income fell to $173,000 from $1,482,000, with EPS dropping to $0.03 from $0.29.
For the first six months, sales rose to $14,494,000 from $11,478,000, a 26% increase in first half sales, and operating income increased to $617,000 from $513,000, a 20% growth in operating income, but net income decreased to $370,000 from $1,426,000, with EPS of $0.07 versus $0.28. Management cites strong demand in livestock-oriented Agricultural Products and continued strength in Modular Buildings, offset by weaker sugar beet equipment demand, elevated inventories, and material cost pressures that are constraining margins.
ARTS WAY MANUFACTURING CO INC reports a Schedule 13G/A filing disclosing beneficial ownership. Larry Walther states he beneficially owns 480,000 shares of Common Stock, equal to 9.2283% (9.2%) of the class. The filing notes 5,201,386 shares outstanding as of June 30, 2026.
Arts Way Manufacturing Co Inc filed an amendment to its Schedule 13G/A reporting beneficial ownership of 480,000 shares of Common Stock, representing 0.092283%.
The filing lists Larry Walther as the reporting person with sole voting and dispositive power over the 480,000 shares. The filing shows a reference date of 06/30/2026 and was signed on 07/06/2026.
Art’s-Way Manufacturing Co., Inc. entered into a new $500,000 reserve revolving credit facility with Bank Midwest to help fund deposits on a new fiberoptic laser and crane system for its Agricultural Products segment.
The Reserve Line of Credit is secondary to the company’s existing $4,000,000 revolving line of credit and will only be used when that primary line reaches capacity. It matures on March 30, 2027 and carries monthly interest-only payments at a rate of 2.600% above the 1‑month SOFR index, with an initial interest rate of 6.225% per year. After delivery and installation of the equipment, expected in 16–18 weeks, the deposits and remaining balance will be converted into term debt with a 15‑year term at an originally estimated interest rate of 6.50% per year, aligning this borrowing with the long‑term nature of the new assets.
Ramsey Randall C. reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC director equity grant: Director Randall C. Ramsey received 1,000 shares of Common Stock on a fully vested basis as a restricted stock grant under the director compensation plan. After this award, he directly holds 78,709 shares of the company’s common stock.
White David Allan reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC director David Allan White received a grant of 1,000 shares of Common Stock as fully-vested restricted stock under the director compensation plan. After this award, he directly holds a total of 51,000 Common Stock shares.
MCCONNELL MARC H reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC President, CEO and Chairman Marc H. McConnell reported updated holdings and a new stock award. On May 31, 2026, he received a grant of 1,000 shares of Common Stock at $0.00 per share, increasing his direct ownership to 256,500 shares.
The filing also lists indirect holdings, including 2,149,819 shares of Common Stock held through McConnell Legacy Investments, LLC, as well as smaller positions held for two children and an IRA. Footnotes explain that the direct total includes fully vested and restricted stock with risks of forfeiture lapsing on specified future dates.
Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC director Thomas E. Buffamante received a stock grant of 1,000 shares of Common Stock as compensation. The award was fully vested restricted stock granted under the director compensation plan and carried no cash purchase price.
After this grant, Buffamante directly owns 64,000 shares of the company’s common stock. Because this is a compensation-related award rather than an open-market trade, it reflects routine equity-based pay for board service rather than an active market purchase or sale decision.
Westendorf Matthew reported acquisition or exercise transactions in this Form 4 filing.
ARTS WAY MANUFACTURING CO INC director Matthew Westendorf received 1,000 shares of Common Stock as a fully vested restricted stock grant. The shares were awarded on May 31, 2026 under the director compensation plan and increased his direct holdings to 32,000 shares. This is a compensation-related equity award rather than an open-market purchase.
Art’s-Way Manufacturing Co., Inc. held its 2026 Annual Meeting of Stockholders on April 21, 2026. Stockholders elected five directors, each receiving over 3.3 million votes in favor, with broker non-votes reported for each nominee.
Stockholders ratified Eide Bailly LLP as independent registered public accounting firm for the fiscal year ending November 30, 2026, with 4,171,196 votes for and limited opposition. They also approved an amendment to the 2020 Equity Incentive Plan to increase shares reserved by 500,000 shares, and supported, on a non-binding advisory basis, the compensation of named executive officers.